Titan Pharmaceuticals
TTNP
#11021
Rank
A$8.76 M
Marketcap
A$6.59
Share price
-3.76%
Change (1 day)
9.27%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$6.73 Million, an increase over its 2023 earnings that were of -A$7.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-35.75%
2024 -A$6.73 Million-15.5%
2023 -A$7.97 Million-45.43%
2022 -A$14.6 Million16.29%
2021 -A$12.55 Million-907.36%
2020 A$1.55 M-106.6%
2019 -A$23.54 Million82.4%
2018 -A$12.91 Million-36.93%
2017 -A$20.46 Million-378.62%
2016 A$7.34 M-145.53%
2015 -A$16.13 Million369.37%
2014 -A$3.44 Million-125.9%
2013 A$13.26 M-177.74%
2012 -A$17.07 Million13.59%
2011 -A$15.03 Million74.37%
2010 -A$8.62 Million3.61%
2009 -A$8.32 Million
2007 -A$26.36 Million12.08%
2006 -A$23.52 Million-28.65%
2005 -A$32.96 Million-10.03%
2004 -A$36.64 Million-6.08%
2003 -A$39.01 Million-14.76%
2002 -A$45.76 Million32.52%
2001 -A$34.53 Million27.55%
2000 -A$27.07 Million62.5%
1999 -A$16.66 Million4.04%
1998 -A$16.02 Million49.33%
1997 -A$10.73 Million-27.88%
1996 -A$14.87 Million13.04%
1995 -A$13.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.46 B-934,431.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.19 B-553,468.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion 6,519.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.10 B-2,748.84%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$15.37 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.47 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA